RolloverTreatment With Triumeq for People With ALS Following the Lighthouse II Trial

Clinical trial NCT06658977 · TERMINATED

Trial details

NCT number: NCT06658977
Sponsor: Macquarie University, Australia
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis ALS

Start date: 2024-11-15
Primary completion: 2025-06-03
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.